Clinical Trial Update: Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose [Phase 3]

View source ↗

Summary

A Phase 3 pilot feasibility and safety trial evaluating weight-adjusted fixed-dose low molecular weight heparin for venous thromboembolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Venous Thromboembolism | Phase 3 | Status: UNKNOWN